
|Articles|December 1, 2002
CMV retinitis treatment responding to changing HIV therapy
Editor's Note: HIV/AIDS continues to be a major health problem, not only in the developing world, but in North America and Europe as well. Although the incidence of ocular complications of HIV/AIDS has decreased dramatically since the introduction of highly active anti-retroviral therapy (HAART), the prevalence of HIV positivity continues toincrease, particularly among heterosexual women and minorities.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
Laru-zova meets primary endpoint in pivotal VISTA trial for X-linked retinitis pigmentosa
2
EyeCon 2026: ODs and MDs pull up a chair
3
Addressing geographic variation in dry eye disease care requires patient-centric approaches
4
How screen time and eyelid health affect dry eye risk
5











